Updated September 2026Labeled product, unlabeled termLumiMeds review
The ingredient, route and pharmacy type are all stated; the plan behind the price is not.
The verdict
LumiMeds publishes semaglutide as low as $89 a month and tirzepatide as low as $125. Four plan lengths are offered. Which one the figure belongs to is never said.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $89/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- LegitScript
- Claimed by provider
LumiMeds sells two compounded GLP-1 lines and an NAD+ line. Each has a product page of its own. The pages are built as spec sheets rather than sales copy.
Who writes the prescription, and what do they see?
A licensed clinician reviews the intake and prescribes only where appropriate. LumiMeds states there are no auto-approvals and promises a full refund where a buyer is not eligible. Providers are described as United States licensed. None is named, and no state list is published.
Dose changes, refills and questions are described as part of the plan rather than add-ons. Shipping is cold-chain and included. Klarna will split any plan into payments, and FSA and HSA cards are accepted on some of them.
What happens when the dose goes up?
LumiMeds states there is no upcharge when the dose goes up, which settles the money question. The product page calls the dosing provider-titrated and once weekly. No milligram is printed, so the ladder itself stays out of view.
What the price includes
The floor is $89 for semaglutide and $125 for tirzepatide. Above those figures sits one line: monthly, three, six and twelve-month options are available. Nothing connects the figure to a term. A buyer cannot tell from the page whether $89 is a month-to-month rate or a year bought at once.
What it claims, and what it cites
Both lines are compounded by a 503A pharmacy against an individual prescription. Compounded drugs are not FDA-approved as a finished product, which LumiMeds states itself. The pharmacy is identified by type rather than by name. The semaglutide page names the active ingredient, its receptor class, the subcutaneous route and the multi-dose vial it ships in.
Where it holds up, and where it does not
- Strength: Active ingredient and drug class named on the page
- Strength: Route, frequency and vial format labeled
- Strength: The 503A pharmacy type is stated
- Strength: LegitScript certification is claimed
- Strength: No upcharge when the dose rises
- Limitation: The plan term behind the price is not stated
- Limitation: No milligram appears on either product page
- Limitation: The pharmacy is named by type only
- Limitation: A three-week onset claim carries no source
What the evidence says about this kind of treatment
The assessment above is about LumiMeds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who wants the ingredient, route and pharmacy type stated before paying.
- Wrong for
- A buyer who needs to know what a single month costs before committing.
How LumiMeds compares
| Seller | Who it suits | Go |
|---|---|---|
 Mondae | Buyers who want a low published compounded rate and few other details | See Mondae → |
 NativeMed | Buyers who want to see the prepay arithmetic before deciding it is a saving | See NativeMed → |
 Spry | Buyers who can read a four-week billing cycle as thirteen charges rather than twelve | See Spry → |
More GLP-1 telehealth sellers reviews: Revel RXRevive MedsRewinding RXRex MDRivas Medical Weight LossRivo Health
Sponsored alternative
Bodybuilding Health+
A reader unwilling to prepay a year before seeing how the drug goes
Check Bodybuilding Health+ availability →Frequently asked
- Is $89 a monthly price?
- Not established. The page offers monthly, three, six and twelve-month plans and does not say which the figure buys.
- Does the charge rise with the dose?
- No. LumiMeds states there is no upcharge when the dose goes up.
- Is the pharmacy named?
- It is identified as a state-licensed 503A compounding pharmacy. No name is given.
- Is LumiMeds expensive compared with other GLP-1 telehealth sellers?
- LumiMeds publishes a starting figure of $89/mo. Across the 252 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $178, which puts LumiMeds below the median, toward the cheaper end. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.